Global /Taiwan /Industrials /Specialty Business Services /7773
chevron_leftBack
FullHope Biomedical Co.,Ltd. logo

FullHope Biomedical Co.,Ltd.

7773
TPEX: 7773 Delayed
26.60TWD -0.6%
0.8407 USD
As of 20 June 2026, FullHope Biomedical Co.,Ltd. has a market cap of $33.57M USD, ranking #33454 globally and #2053 in Taiwan. It ranks #7641 in the Industrials sector, and #929 in the Specialty Business Services industry.
Global Rank
33454
Country Rank
2053
Sector Rank
7641
Industry Rank
929
Key Stats
Market Cap
$33.57MUSD
1.06B TWD
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
Founded
2012
Website
fhb.com.tw open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.6% -4.8% 6.6% -14% -27% -33%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
7773
富禾生醫股份有限公司
ISIN: TW0007773004
Shares Out.:
39.911M1
TV:
SA:
YF:
GF:
BA:
MS:
26.60 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About FullHope Biomedical Co.,Ltd.

FullHope Biomedical Co.,Ltd. engages in the research and development of immune system-related services. It develops FHCT001 and FHCT003, an immune cell therapies for cancer; and FHCT002, an auto-immune cell therapy, as well as diagnostic tools. The company also provides various services, including immunoprofiling, circulating tumor cells testing, regulation of cell therapy, contracting immune cell manufacturing, immune cell bank, contract research organization, and endotoxin and mycoplasma detection. FullHope Biomedical Co.,Ltd. was founded in 2012 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Specialty Business Services (Taiwan)
Name
Market Cap diff.
PE
$10.96B
346.65B TWD
33K%
43.7
3264
$2.99B
94.55B TWD
9K%
33.6
$2.69B
84.98B TWD
8K%
31.1
$1.9B
60.17B TWD
6K%
-
$1.61B
50.84B TWD
5K%
16.9
$1.57B
49.77B TWD
5K%
-
Industry: Specialty Business Services (Global)
Name
Market Cap diff.
PE
SHOP
$158.14B
471K%
129.8
VSURE
$131.55B
114.8B EUR
392K%
-
CTAS
$69.6B
207K%
36.8
REL
$62.85B
47.6B GBP
187K%
23.9
PYPL
$45.83B
136K%
9.4
$41.8B
56.91B CAD
124K%
-
chevron_leftBack